Th2-polarised PrP-specific Transgenic T-cells Confer partial protection against Murine Scrapie

PLoS Pathogens

Volumn 7, Issue 9, 2011, Pages

  Iken, Saci ^a,b   Bachy, Véronique ^a,b   Gourdain, Pauline ^a,b,d   Lim, Annick ^c   Grégoire, Sylvie ^a,b,e   Chaigneau, Thomas ^a,b   Aucouturier, Pierre ^a,b   Carnaud, Claude ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c INSTITUT PASTEUR   (France)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; INTERLEUKIN 4; PRION PROTEIN; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

ADOPTIVE TRANSFER; ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA CHAIN; CD4+ T LYMPHOCYTE; CELL POLARITY; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; HUMORAL IMMUNITY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SCRAPIE; TH2 CELL; TRANSGENIC ORGANISM; ANIMAL; COMPLEMENTARITY DETERMINING REGION; GENE REARRANGEMENT; IMMUNOLOGY; PRION; TRANSGENIC MOUSE; TRANSPLANTATION;

MURINAE; MUS; MUS MUSCULUS;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COMPLEMENTARITY DETERMINING REGIONS; GENE REARRANGEMENT, ALPHA-CHAIN T-CELL ANTIGEN RECEPTOR; INTERLEUKIN-4; MICE; MICE, TRANSGENIC; PRIONS; PRPSC PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SCRAPIE; TH2 CELLS;

EID: 80053524656     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002216     Document Type: Article

References (54)

1. Aguzzi A, Calella AM, (2009) Prions: protein aggregation and infectious diseases. Physiol Rev 89: 1105-1152.
2. Prusiner SB, (1998) Prions. Proc Natl Acad Sci U S A 95: 13363-13383.
3. Heppner FL, Musahl C, Arrighi I, Klein MA, Rulicke T, et al. (2001) Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294: 178-182.
4. White AR, Enever P, Tayebi M, Mushens R, Linehan J, et al. (2003) Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422: 80-83.
5. Zuber C, Mitteregger G, Pace C, Zerr I, Kretzschmar HA, et al. (2007) Anti-LRP/LR antibody W3 hampers peripheral PrPSc propagation in scrapie infected mice. Prion 1: 207-212.
6. Goni F, Prelli F, Schreiber F, Scholtzova H, Chung E, et al. (2008) High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice. Neuroscience 153: 679-686.
7. Sacquin A, Bergot AS, Aucouturier P, Bruley-Rosset M, (2008) Contribution of antibody and T cell-specific responses to the progression of 139A-scrapie in C57BL/6 mice immunized with prion protein peptides. J Immunol 181: 768-775.
8. Schwarz A, Kratke O, Burwinkel M, Riemer C, Schultz J, et al. (2003) Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci Lett 350: 187-189.
9. Gregoire S, Bergot AS, Feraudet C, Carnaud C, Aucouturier P, et al. (2005) The murine B cell repertoire is severely selected against endogenous cellular prion protein. J Immunol 175: 6443-6449.
10. Polymenidou M, Heppner FL, Pellicioli EC, Urich E, Miele G, et al. (2004) Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc Natl Acad Sci U S A 101(Suppl 2): 14670-14676.
11. Carnaud C, Bachy V, (2010) Cell-based immunotherapy of prion diseases by adoptive transfer of antigen-loaded dendritic cells or antigen-primed CD4+ T lymphocytes. Prion 4: 66-71.
12. Bachy V, Ballerini C, Gourdain P, Prignon A, Iken S, et al. (2010) Mouse vaccination with dendritic cells loaded with prion protein peptides overcomes tolerance and delays scrapie. J Gen Virol 91: 809-820.
13. Gourdain P, Gregoire S, Iken S, Bachy V, Dorban G, et al. (2009) Adoptive transfer of T lymphocytes sensitized against the prion protein attenuates prion invasion in scrapie-infected mice. J Immunol 183: 6619-6628.
14. Teh HS, Kishi H, Scott B, Borgulya P, von Boehmer H, et al. (1990) Early deletion and late positive selection of T cells expressing a male-specific receptor in T-cell receptor transgenic mice. Dev Immunol 1: 1-10.
15. Killeen N, Davis CB, Chu K, Crooks ME, Sawada S, et al. (1993) CD4 function in thymocyte differentiation and T cell activation. Philos Trans R Soc Lond B Biol Sci 342: 25-34.
16. Bill J, Kanagawa O, Linten J, Utsunomiya Y, Palmer E, (1990) Class I and class II MHC gene products differentially affect the fate of V beta 5 bearing thymocytes. J Mol Cell Immunol: 4: 269-279; discussion 279-280.
17. Sakaguchi S, (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562.
18. Gregoire S, Logre C, Metharom P, Loing E, Chomilier J, et al. (2004) Identification of two immunogenic domains of the prion protein-PrP-which activate class II-restricted T cells and elicit antibody responses against the native molecule. J Leukoc Biol 76: 125-134.
19. Dillon SR, Jameson SC, Fink PJ, (1994) V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition. J Immunol 152: 1790-1801.
20. Enari M, Flechsig E, Weissmann C, (2001) Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci U S A 98: 9295-9299.
21. Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, et al. (2001) Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412: 739-743.
22. Sigurdsson EM, Sy MS, Li R, Scholtzova H, Kascsak RJ, et al. (2003) Anti-prion antibodies for prophylaxis following prion exposure in mice. Neurosci Lett 336: 185-187.
23. Wojtera M, Sikorska B, Sobow T, Liberski PP, (2005) Microglial cells in neurodegenerative disorders. Folia Neuropathol 43: 311-321.
24. Orgogozo JM, Gilman S, Dartigues JF, Laurent B, Puel M, et al. (2003) Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 61: 46-54.
25. Schwartz M, Shechter R, (2010) Systemic inflammatory cells fight off neurodegenerative disease. Nat Rev Neurol 6: 405-410.
26. Acha-Orbea H, Mitchell DJ, Timmermann L, Wraith DC, Tausch GS, et al. (1988) Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54: 263-273.
27. Hochgeschwender U, Weltzien HU, Eichmann K, Wallace RB, Epplen JT, (1986) Preferential expression of a defined T-cell receptor beta-chain gene in hapten-specific cytotoxic T-cell clones. Nature 322: 376-378.
28. Yanagi Y, Maekawa R, Cook T, Kanagawa O, Oldstone MB, (1990) Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus. J Virol 64: 5919-5926.
29. Brandle D, Burki K, Wallace VA, Rohrer UH, Mak TW, et al. (1991) Involvement of both T cell receptor V alpha and V beta variable region domains and alpha chain junctional region in viral antigen recognition. Eur J Immunol 21: 2195-2202.
30. Verdaguer J, Yoon JW, Anderson B, Averill N, Utsugi T, et al. (1996) Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains. J Immunol 157: 4726-4735.
31. Yokosuka T, Takase K, Suzuki M, Nakagawa Y, Taki S, et al. (2002) Predominant role of T cell receptor (TCR)-alpha chain in forming preimmune TCR repertoire revealed by clonal TCR reconstitution system. J Exp Med 195: 991-1001.
32. Blackman MA, Smith HP, Le P, Woodland DL, (1993) Influence of the T cell receptor alpha-chain on T cell reactivity and tolerance to Mls-1 in T cell receptor beta-chain transgenic mice. J Immunol 151: 556-565.
33. Freitas AA, Rocha B, (1999) Peripheral T cell survival. Curr Opin Immunol 11: 152-156.
34. Ballerini C, Gourdain P, Bachy V, Blanchard N, Levavasseur E, et al. (2006) Functional implication of cellular prion protein in antigen-driven interactions between T cells and dendritic cells. J Immunol 176: 7254-7262.
35. Heikenwalder M, Polymenidou M, Junt T, Sigurdson C, Wagner H, et al. (2004) Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med 10: 187-192.
36. Mabbott NA, Mackay F, Minns F, Bruce ME, (2000) Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nat Med 6: 719-720.
37. Montrasio F, Frigg R, Glatzel M, Klein MA, Mackay F, et al. (2000) Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288: 1257-1259.
38. Raymond CR, Aucouturier P, Mabbott NA, (2007) In vivo depletion of CD11c+ cells impairs scrapie agent neuroinvasion from the intestine. J Immunol 179: 7758-7766.
39. Aucouturier P, Geissmann F, Damotte D, Saborio GP, Meeker HC, et al. (2001) Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J Clin Invest 108: 703-708.
40. Beringue V, Couvreur P, Dormont D, (2002) Involvement of macrophages in the pathogenesis of transmissible spongiform encephalopathies. Dev Immunol 9: 19-27.
41. Carp RI, Callahan SM, (1982) Effect of mouse peritoneal macrophages on scrapie infectivity during extended in vitro incubation. Intervirology 17: 201-207.
42. Beringue V, Le Dur A, Tixador P, Reine F, Lepourry L, et al. (2008) Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD. PLoS ONE 3: e1419.
43. Loeuillet C, Lemaire-Vieille C, Naquet P, Cesbron-Delauw MF, Gagnon J, et al. (2010) Prion replication in the hematopoietic compartment is not required for neuroinvasion in scrapie mouse model. PLoS ONE 5: e13166.
44. Derecki NC, Cardani AN, Yang CH, Quinnies KM, Crihfield A, et al. (2010) Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med 207: 1067-1080.
45. Shechter R, London A, Varol C, Raposo C, Cusimano M, et al. (2009) Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 6: e1000113.
46. Ziv Y, Ron N, Butovsky O, Landa G, Sudai E, et al. (2006) Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci 9: 268-275.
47. Falsig J, Julius C, Margalith I, Schwarz P, Heppner FL, et al. (2008) A versatile prion replication assay in organotypic brain slices. Nat Neurosci 11: 109-117.
48. Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J, (2011) Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470: 540-542.
49. Butovsky O, Landa G, Kunis G, Ziv Y, Avidan H, et al. (2006) Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest 116: 905-915.
50. Chao CC, Hu S, Peterson PK, (1995) Modulation of human microglial cell superoxide production by cytokines. J Leukoc Biol 58: 65-70.
51. Ponomarev ED, Maresz K, Tan Y, Dittel BN, (2007) CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 27: 10714-10721.
52. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, et al. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577-582.
53. Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, et al. (1993) The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci U S A 90: 4319-4323.
54. Lim A, Baron V, Ferradini L, Bonneville M, Kourilsky P, et al. (2002) Combination of MHC-peptide multimer-based T cell sorting with the Immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses. J Immunol Methods 261: 177-194.